CI

At a glance

ClinicalIndex Comparison Record
Phase 3Completed· 47 enrolled
Drug / intervention
UC Home Automated Telemanagement +1 moreother
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT00620126
NCT00620126Phase 3Completed
CompareCT.gov

The Home Telemanagement (UC HAT) Trial for Patients With Ulcerative Colitis

University of Maryland, Baltimore·interventional·Posted Feb 21, 2008·Updated Nov 13, 2019

In Brief

A Phase 3 clinical trial evaluating UC Home Automated Telemanagement and Best Available Care for Inflammatory Bowel Disease and Ulcerative Colitis. Completed, enrolled 47 participants across 2 sites.

Detailed Summary

The purpose of this study is to determine if home automated telemanagement improves bowel symptoms, quality of life, compliance with medications, and health care utilization compared to best available care in patients with ulcerative colitis.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsInflammatory Bowel Disease, Ulcerative Colitis
CountriesUnited States
CollaboratorsThe Broad Foundation, University of Maryland, College Park, Baltimore Research & Education Foundation, Inc., Baltimore VA Medical Center

Timeline

Phase 3CompletedFinished
20082009201020112012201320142015201620172018201920202021202220232024202520262027
First PostedFeb 21, 2008
Enrollment StartJan 1, 2008
Primary CompletionFeb 1, 2010
TodayJul 2, 2026
Enrollment to primary: 2.1 yearsPosted 18.4 years ago

Interventions

UC Home Automated Telemanagementother

Weekly assessment with UC Home Automated Telemanagement

Best Available Careother

Routine follow up visits and as needed telephone calls and clinic visits, written action plans, educational fact sheets from the CCFA